Biossimilares em oncologia.

Autor: Sérgio Barroso, Jorge Coutinho, Margarida Damasceno, José Dinis, João Forjaz de Lacerda, Helena Gervásio, Fernando Leal da Costa, Ana Marques Pereira, António Parreira, Fernando Principe, Helena Rodrigues, Anabela Sá, Adriana Teixeira

Publikováno v: Acta Médica Portuguesa, Vol 22, Iss 3 (2009)

The development of biotechnology drugs represents one of the great advances in medical therapy and it was observed an exponential growth in its use. The resource to these drugs in Oncology and Hematology is no exception and it soon became an essentia

Externí odkaz: https://doaj.org/article/267b7c399f184c4db8af803f4ede0f88

Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature

Autor: Emanuel Dias, Rodrigo Liberal, Pedro Costa-Moreira, Fernando Príncipe, Elsa Fonseca, Guilherme Macedo

Publikováno v: GE: Portuguese Journal of Gastroenterology, Pp 1-7 (2021)

Introduction: Myeloproliferative neoplasms are the most common cause of splanchnic vein thrombosis in the absence of cirrhosis or nearby malignancy. Case Presentation: A 31-year-old male presented to the emergency department with epigastric pain asso

Externí odkaz: https://doaj.org/article/125db16a1f514d06ae42b16e966275e2

Pharmacokinetic and phototherapeutic studies of monocationic methoxyphenylporphyrin derivative

Autor: Silvia Romanini, Mabel Bertuzzi, Jorge R. Bergesse, Viviana Rivarola, M. Cristina Romanini, Fernando Principe, M. Gabriela Alvarez, N. Belén Rumie Vittar, Edgardo N. Durantini

Publikováno v: Photodiagnosis and photodynamic therapy. 1(4)

Summary Background and objetive: Photodynamic therapy, a novel treatment for cancer, works through photoactivation of a tumor-localized photosensitive drug, and localized through oxidative damage to kill cells and ablate tumors. Pharmacokinetic and p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04bbf36f12dbe4e972cb49d012f23fe8
https://pubmed.ncbi.nlm.nih.gov/25048437

Febrile Neutropenia Risk Assessment and Granulocyte-Colony Stimulating Factor Support in Patients with Diffuse Large B Cell Lymphoma Receiving R-CHOP Regimens

Autor: Ulrich Jaeger, Ulrich Duehrsen, Hans Erik Johnsen, Matthias Schwenkglenks, Ruth Pettengell, Antonio Salar, Kate Bendall, Gregor Verhoef, Pieternella J. Lugtenburg, Francesca Gaia Rossi, Fernando Principe, P. Bacon, Corinne Haioun

Publikováno v: Aalborg University
Salar, A, Haioun, C, Rossi, F G, Duehrsen, U, Pettengell, R, Johnsen, H E, Jaeger, U, Verhoef, G, Schwenkglenks, M, Principe, F, Bacon, P, Bendall, K & Lugtenburg, P J 2009, ' Febrile Neutropenia Risk Assessment and Granulocyte-Colony Stimulating Factor Support in Patients with Diffuse Large B Cell Lymphoma Receiving R-CHOP Regimens ', Blood, no. 22, pp. 107 .

BACKGROUND: ASCO and EORTC guidelines recommend granulocyte colony-stimulating factor (G-CSF) primary prophylaxis for cancer patients with a ≥20% overall risk of febrile neutropenia (FN), and to support delivery of dose-dense regimens. CHOP-like re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::886fe2ed305f51aa1ac8672215dca8a0
http://vbn.aau.dk/en/publications/febrile-neutropenia-risk-assessment-and-granulocytecolony-stimulating-factor-support-in-patients-with-diffuse-large-b-cell-lymphoma-receiving-rchop-regimens(146a991c-b767-49af-83d5-6b96d98d35bd).html